Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014
NYSE to expand number of companies on biotech index
Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With Spinal Muscular Atrophy
Alnylam Reports Six-Month Clinical Data from Patisiran Phase 2 Open-Label Extension (OLE) Study in Patients with Familial Amyloidotic Polyneuropathy (FAP)
Research and Markets: Global Biological Drugs Market Outlook 2020
Research and Markets: Global Cancer Monoclonal Antibodies Market & Pipeline Insight 2014
All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...
Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.